Skip to main content
Have a personal or library account? Click to login
Comparison between two cyclooxygenase inhibitors in an experimental dry eye model in albino rabbits Cover

Comparison between two cyclooxygenase inhibitors in an experimental dry eye model in albino rabbits

Open Access
|May 2008

References

  1. A. Gulati and R. Dana, Keratoconjunctivitis sicca, Clinical aspects, in(Eds C. S. Foster, D. T. Azar and C. H. Dohlam), 4ed., Lippincot, Williams and Wilkins, Philadelphia 2005, pp. 603-626.
  2. R. I. Fox and M. Stern, Sjogren's syndrome: Mechanisms of pathogenesis involve interaction of immune and neurosecretory systems,31 (2003) 3-13; DOI: 10.1080/030097402317474874.
  3. S. C. Pflugfelder, Anti-inflammatory therapy of dry eye,137 (2004) 337-342; DOI: 10.1016/J.ajo.2003.10.036.
  4. L. Libui, D. Li, A. Doshi, W. Farely, R. M. Corrales and S. C. Pflugfelder, Experimental dry eye stimulates the production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface,Ophthamol.45 (2004) 4293-4301; DOI: 10.1167/iovs.03-1145.
  5. A. Solomon, D. Dursun and Z. Liu, Pro and anti-inflammatory forms of interleukins in the tear fluid and conjunctiva of patients with dry eye disease,42 (2001) 2283-2292.
  6. T. J. Nagelhaut, D. A. Gamache, L. Roberts, M. T. Brady and J. M. Yanni, Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye,21 (2005) 139-148; DOI: 10.1089/JOP.2005.21.139.
  7. L. D. Waterbury, D. Silliman and T. Jalas, Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium,22 (2006) 1133-1140; DOI: 10.1185/03 0079906x112471.
  8. J. Damm, T. Rau and A. Pah, Constitutive expression and localization of COX-1 and COX-2 in rabbit iris and ciliary body,72 (2001) 611-621; DOI: 10.1006/exer.2001.0977.
  9. A. Bertolini, A. Ottani and M. Sandrini, Selective COX-2 inhibitors and dual acting anti-inflammatory drugs, critical remarks,9 (2002) 1033-1034; DOI: 10.2174/0929867-024606650.
  10. A. A. Steiner, S. Li, Q. J. Lianos and C. M. Blatteis, Differential inhibition by nimesulide of the early and late phases of intravenous and intracerebral neuroimmunomodulation, 9 (2001) 263-275; DOI: 10.1159/000054289.
  11. S. Burgalassi, L. Panichi, P. Chetoni, M. F. Saettone and E. Boldrini, Development of a simple dry eye model in the albino rabbit and evaluation of some tear substituents,31 (1999) 229-235; DOI: 10.1159/000055537.
  12. X. U. Li, L. Hu, J. Hu and W. Wang, Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery,26 (2007) 516-520; DOI: 10.1097/ico.0b013e31812f67ca.
  13. L. S. Mengher, A. J. Bron, S. R. Tonge and D. J. Gilbert, Non-invasive instrument for clinical assessment of the precorneal tear film stability,4 (1985) 1-7.
  14. C. Tamer, I. M. Melek, T. Duman and H. Oksuiz, Tear film tests in Parkinson's disease patients,112 (2005) 1795-1800; DOI: 10.1016/J.ophtha.2005.04.025.
  15. M. D. Sternlicht and Z. Werb, How matrix metalloproteinases regulate cell behavior,17 (2001) 463-516; DOI: 10.1146/annurev.Cellbio.17.1.463.
  16. D. Dursun, M. Wang, D. Monroy, D. Li, M. E. Stern and S. C. Pflugfelder, A mouse model of KCS,43 (2002) 632-638.
  17. P. Marsh and S. C. Pflugfelder, Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren's syndrome,106 (1999) 811-816; DOI: 10.1016/50161-6420(99)90171-9.
  18. R. Schalnus, Topical non steroidal anti-inflammatory therapy in ophthalmology,217 (2003) 89-98; DOI: 10.1159/000068563.
  19. S. E. Wilson and H. D. Perry, Long term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment,114 (2007) 76-79; DOI: 10.1016/J.ophtha.2006.05.077.
DOI: https://doi.org/10.2478/v10007-008-0009-0 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English, Croatian
Page range: 163 - 173
Published on: May 30, 2008
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2008 Amany EL-Shazly, Amal EL-Gohary, Laila EL-Shazly, Ghada EL-Hossary, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.